Interleukin-6 (IL-6) is produced by many different cell types. Human skeletal muscles produce and release high amounts of IL-6 during exercise; however, the cell source of origin in the muscle is not known. Therefore, we studied the protein expression of IL-6 by immunohistochemistry in human muscle tissue from biopsies obtained at time points 0, 3, 4.5, 6, 9, and 24 h in relation to 3 h of bicycle exercise performed by healthy young males (n=12) and in resting controls (n=6). The IL-6 expression was clearly increased after exercise and remained high even by 24 h, relative to preexercise or resting individuals. The IL-6 immunostainings of skeletal muscle cells were homogeneous and without difference between muscle fiber types. The IL-6 mRNA peaked immediately after the exercise, and, in accordance, the IL-6 protein expression within muscle cells was most pronounced around 3 h post-exercise. However, the finding that plasma IL-6 concentration peaked in the end of exercise indicates a high turnover of muscle-derived IL-6. In conclusion, the finding of marked IL-6 protein expression exclusively within skeletal muscle fibers following exercise demonstrates that skeletal muscle fibers of all types are the dominant cell source of exercise-induced release of IL-6 from working muscle.
t is well known that the cytokine interleukin-6 (IL-6) is markedly increased during exercise. Thus, plasma IL-6 increases in an exponential fashion and peaks at the end of an exercise bout (for reference, see 1, 2). IL-6 is highly regulated by the onset of exercise and is also linked to energy availability within the working skeletal muscle, as subjects with low intra-muscular glycogen levels demonstrate a further enhanced IL-6 response independent of blood-borne substrates or hormones, which is initiated by the onset of exercise (3, 4) . Furthermore, IL-6 has recently been demonstrated to have a lipolytic effect upon infusion in human subjects (5) and may thus work as a muscle-derived hormone, released in high amounts from skeletal muscle to mobilize energy as free fatty acids from adipose tissue. Although earlier studies demonstrated that IL-6 mRNA is increased in skeletal muscle biopsy samples (3, 4, 6) and that IL-6 is released by contracting muscles (7), it has not previously been documented which cell type within the muscle is responsible for the production. Whereas myoblasts have been shown to be capable of producing 9) , endothelial cells (10) , fibroblasts (9) , and smooth muscle cells (11) have also been shown to produce IL-6 under certain circumstances. Thus, several cell types in the skeletal organ have the potential to produce IL-6. However, for IL-6 to play a role as an energy-sensing muscle-derived hormone, it must be secreted from the tissue in need of energy; the myotubes.
In an attempt to determine which cells produce the IL-6, we have isolated nuclei from human muscle biopsies obtained before, during, and after exercise and demonstrated that the nuclear transcription rate for IL-6 increased rapidly and markedly after the onset of exercise (4) . Furthermore, myoblasts stimulated with ionomycin, an agent that mimics the exercise-induced increase in intracellular calcium levels, have demonstrated an increase in IL-6 mRNA (Keller et al., unpublished data). Thus, it is plausible that the muscle cells themselves are the source of IL-6 production during exercise. The aim of the present study, therefore, was to address the question of whether muscle fibers are the major producers of IL-6 in response to exercise. Muscle-derived IL-6 is a consequence of transcription and translation of the IL-6 gene in the skeletal muscle organ. Transcription has been demonstrated in human muscle already after 30 min of moderate exercise (4) . The concentration of the IL-6 protein in plasma increases in an exponential fashion with duration of exercise (1) . Although, the intensity of exercise is also a determining factor (12), we chose an exercise model of long duration and consequently somewhat moderate intensity. We chose ergometer bicycling as mode of exercise, as we wanted a pure concentric exercise model in order to exclude a classical acute phase response as can be elicited by muscle damage induced by eccentric exercise.
MATERIALS AND METHODS
Eighteen healthy male subjects [age median 27 years (range [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] , height 189 cm (range 164-197), weight 80 kg (range 64-96)] participated in the study. The subjects were given both oral and written information about the experimental procedures before giving their written informed consent. The study was approved by the Copenhagen and Frederiksberg Ethics Committee, Denmark, and was performed according to the declaration of Helsinki.
One week before the first experimental day, subjects performed a maximal oxygen uptake test (VO 2 max) on an ergometer bicycle. Measurement of maximum VO 2 was performed on an electrically braked cadence independent cycle ergometer (Monark 839E, Monark Ltd., Varberg, Sweden). Subjects cycled for 3 min at 100 Watts as a warm-up followed by cycling at progressively higher work rates, increasing 50 Watts every 3 min for 9 min and then increasing the workload by 25 W every minute until subjects were unable to maintain a cadence of 60 rpm. Expired oxygen (VO 2 ) and carbon dioxide (VCO 2 ) concentrations were recorded online. Median VO 2 max was median 46.7 ml/kg x min (range 41-68). At the experimental day, subjects arrived at 8 am after an overnight fast and were randomized to either exercise or rest. There was no difference between the two groups with regard to age, weight, height, or VO 2 max. Subjects performed 3 h of cycling at 60% of VO 2 max followed by 6 h of recovery. The following day they reported to the laboratory after an overnight fast. Prior to the exercise (0); immediately after the exercise (+3 h); and 4.5, 6, 9, and 24 h after, muscle biopsies were obtained from the vastus lateralis by using the percutaneous needle biopsy technique with suction. Control subjects rested in the laboratory for 9 h and had biopsies collected to time points 0, 3, 4.5, 6, and 9 h. They reported to the laboratory the following day, where the last biopsy was obtained at time point 24 h.
Histochemistry and immunohistochemistry
Muscle tissue was cut in 6 µm consecutive sections on a cryostat, and the sections were immediately collected on glass slides, to be used for general histology and immunohistochemistry.
For epitope retrieval, sections were pre-incubated in Digest-ALL-3 (Pepsin solution) (Zymed Lab. Inc., San Francisco, CA, code 00-3009) for 5 min followed by incubation in 10% goat serum (Company In Vitro AS, Fredensborg, DK, code 04009-1B) in TBS (TBS: 0.05 M TRIS, pH 7.4, 0.15 M NaCl) with 0.01% Nonidet P-40 (TBS/Nonidet) for 30 min at room temperature.
Histochemistry: Hematoxylin and eosin (HE) stainings of the sections were performed according to standard procedures (13). Myofibrillar ATPase staining with preincubations of pH 4.6 was used to identify muscle fiber types (14) .
Immunohistochemistry: Sections were incubated overnight at 4°C with monoclonal mouse antihuman IL-6 diluted 1:50 (Chemicon Int. Inc./Cymbus, Temecula, CA; code CBL2117). The primary antibody was detected by using biotinylated goat anti-mouse IgG diluted 1:200 (SigmaAldrich, Vallensbaek, DK; code B8774) for 30 min at room temperature followed by streptavidinbiotin-peroxidase complex (StreptABComplex/HRP, Dakopatts, Glostrup, DK; code K377) prepared at manufacturer's recommended dilutions for 30 min at room temperature. Afterwards, sections were incubated with biotinylated tyramide and streptavidin-peroxidase complex (NEN, Life Science Products, Boston, MA; code NEL700A) prepared following manufacturer's recommendations. The immunoreaction was visualized by using 0.015% H 2 O 2 in 3,3-diaminobenzidine-tetrahydrochloride (DAB)/TBS for 10 min at room temperature.
To evaluate the extent of non-specific binding in the immunohistochemical experiments, control sections were incubated in the absence of primary antibody. Results were considered only if these controls were negative. For the simultaneous examination and recording of the stainings, a Zeiss Axioplan2 light microscope was used.
RNA extraction: RNA was extracted by using Trizol™ (Life Technologies) according to manufacturer's protocol. In short, 1 ml of Trizol was added to 20-50 mg of tissue and homogenized by using a Polytron (PT-MR2100, Kinematica AG, Headquarters, Littau-Lucerne, Schwitzerland) on setting 25-30 for 20-30 s. Chloroform (100 µl) was added to the samples, followed by a 5-min incubation on ice. Samples were spun at 13,000 rpm for 15 min at 4°C (Heraeus Biofuge Pico, DJB Labcare, Newport Pagnell, UK), and the upper aqueous phase was placed in a fresh eppendorf tube. The same volume of isopropanol was added, and samples were placed at -20°C for 1 h followed by centrifugation at 13,000 rpm for 15 min at 4°C. The resulting RNA pellet was washed with 500 µl of 75% ethanol in DEPC-treated water and spun at 8000 rpm for 10 min at 4°C. The pellets were dissolved in 15 µl of DEPC-treated water Reverse transcription: Total RNA (1 µm) was reverse-transcribed in a 50 µl reaction containing 1 × Taqman RT-buffer, 5.5 mM MgCl 2 , 500 µM of each dNTP, 2.5 µM of Oligo dT primers, 0.4 U/µl of RNase inhibitor, and 1.25 U/µl of reverse transcriptase. The reactions were run in a Perkin Elmer GeneAmp PCR system 9700 (PerkinElmer Life and Analytical Sciences, Inc., Boston, MA) with conditions at 25°C for 10 min, 48°C for 30 min, and 95°C for 5 min.
Samples were analyzed for IL-6 mRNA levels by real-time PCR by using an ABI PRISM 7700 sequence detector (PE Biosystems). The gene expression levels were normalized to the housekeeping gene GADPH (obtained from Applied Biosystems). Human IL-6 primers and Taqman® probes (see Table 1 ) were designed using the Primer Express 2.0 program.
Measurement of plasma IL-6
Blood samples for measurement of cytokines were drawn into glass tubes containing EDTA. The tubes were spun immediately at 3500 g for 15 min at 4°C (Sigma 4K15 centrifuge). The plasma was stored at -80°C until analyses were performed. High-sensitivity enzyme-linked immunosorbent assay (ELISA) kits from R&D Systems (Minneapolis, MN) were used to measure IL-6 in plasma; sensitivity: 0.094 pg/mL. This kit does not distinguish between soluble and receptor-bound IL-6 and therefore gives a measure of the total IL-6 content in the sample.
Statistics
IL-6 mRNA data were normally distributed after log-transformation. A one-way ANOVA with correction for multiple time-points (RM-ANOVA) was used to detect a time effect (IL-6 mRNA and plasma-IL-6), with Student-Newman-Keuls t-test for post hoc analysis of changes from resting values. P values <0.05 are considered significant. Statistical calculations were performed using Sigma Stat 3.0 (SSPS Inc., Chicago, IL).
RESULTS

IL-6 immunohistochemistry
IL-6 staining was performed at time points 0, 3, 4.5, 6, 9, and 24 h for 12 subjects who performed exercise for 3 h and at the same time points for 6 subjects at rest.
In the muscle tissue from resting volunteers, the IL-6 staining was absent. Representative data are shown for time points 0 and 6 h (one resting subject) (Fig. 1A-B ) and for one subject before exercise (Fig. 1C ). Right after exercise ended (3 h), the expression of IL-6 had increased significantly (Fig. 1C, D) . The IL-6 levels remained significantly increased by 4.5, 6, and 9 h; whereas, by 24 h, the expression of IL-6 had clearly decreased again ( Fig. 1E-H) . However, the IL-6 levels by 24 h were still higher than those of resting muscles. The IL-6 staining appeared exclusively as a homogeneous staining of the cytoplasm of skeletal muscle fibers in all subjects who had performed exercise. There was no IL-6 staining present between muscle fibers. When myofibrillar staining was compared with IL-6 staining, it appeared that there was no difference between muscle fiber types (Type I, Type IIa, or Type 2x) with regard to IL-6 expression (Fig. 2) .
IL-6 mRNA and plasma-IL-6
The IL-6 mRNA level increased (P<0.05) with exercise. Thus, compared with the prevalue, fold changes of IL-6 mRNA compared with pre-value were 11.0 + 2.6; 8.0+5.7-fold; 1.4+0.4; 0.4+0.2; and 1.2+0.3 at 3, 4.5, 6, 9, and 24 h, respectively-peaking at the end of exercise. Furthermore, plasma IL-6 concentrations increased significantly with time: 2.2+0.2; 18.6+2.8; 16.9+3.9; 9.5+1.5; 9.1+1.4; and 3.1+ 1.7 pg/ml at time points 0, 3, 4.5, 6, 9, and 24 h. There was no sign of muscle damage as indicated by measurement of creatine kinase and myoglobin.
DISCUSSION
The present study demonstrated that physical exercise induces expression of the IL-6 protein in the cytoplasm of muscle fibers. The finding of a marked IL-6 protein expression within skeletal muscle fibers strongly indicates that exercise-induced release of IL-6 from working muscle, the so-called muscle-derived IL-6, has its origin from muscle cells per se. The fact that IL-6 is exclusively located in the cytoplasm of muscle fibers and that there is no IL-6 staining present between muscle fibers supports IL-6 as a genuinely muscle fiber-derived factor. Although, brain (15) and peritendon tissue have been demonstrated to release IL-6 in response to exercise (16) , it seems plausible that muscle fibers are the major source of IL-6 in response to exercise, given the massive protein expression in the muscle fibers in addition to muscle cells being the dominant cell type within skeletal muscle. Furthermore, it has been established that blood mononuclear cells do not contribute to the production of IL-6 during exercise (17) .
Several studies have demonstrated a large increase in IL-6 gene expression in skeletal muscle biopsies (3, 4, 6) . Numerous studies have demonstrated that the IL-6 mRNA in muscle biopsies peak in the end of exercise or shortly after (3, 4, 6) in accordance with the findings from this study.
Furthermore, transcription rates of IL-6 are increased in isolated myonuclei in response to exercise (4) . The IL-6 mRNA kinetic fits nicely with the finding that the IL-6 protein expression within muscle fibers peaked at 6 h (3 h post-exercise). Numerous studies have also demonstrated that the plasma-IL-6 levels increase in an exponential fashion during exercise, peak at the end of exercise or shortly after, and thereafter gradually decline (1). However, it has also been demonstrated that the release of IL-6 from an exercising limb is ~17-fold higher than the amount that is accumulated in the plasma (7), thus indicating a very high turnover of IL-6. The finding of IL-6 protein accumulation within skeletal muscle fibers 3 h after the exercise further supports the idea of a high IL-6 turnover.
As discussed, we have previously demonstrated that the nuclear transcriptional rate of the IL-6 gene is remarkably rapid after the onset of exercise, with a 10-to 20-fold increase when comparing 30 min of exercise with rest. We therefore hypothesized that this rapid increase in nuclear transcriptional rate was related to a glycogen-independent mechanism, possibly the cytosolic Ca 2+ levels, because mechanical load is a potent stimulus for liberating Ca 2+ from the lateral sacs of the sarcoplasmic reticulum (18) . Therefore, muscle cells isolated from human biopsies were harvested and grown in a culture medium until they fused into myotubes (19) and then stimulated with the Ca 2+ ionophore ionomycin. IL-6 mRNA increased progressively over 48 h compared with preincubation levels. It is clear from an examination of the literature that there is a signaling cascade in other cell types that indeed implicates intracellular Ca 2+ ion concentration ([Ca   2+ ] i ) as a potent signaling factor for IL-6 transcription. Ca ] i rise, whereas activation of NFAT was induced by a low sustained [Ca 2+ ] i . Therefore, we previously proposed (1) that during prolonged contractile activity that results in an increase in IL-6 mRNA in skeletal muscle (3, 4, 6, 23) , initial IL-6 transcription occurs via a Ca 2+ /NFAT-dependent pathway. Although NFAT in itself can lead to cytokine gene transcription, it can bind to the transcription factor AP-1, which can lead to cytokine gene transcription (24, 25) . Although this pathway is likely to lead to IL-6 gene transcription during sustained muscular contractions, it is possible that large [Ca 2+ ] i transients as seen with maximal contraction can activate IL-6 via NF-κB and JNK. It is known that skeletal muscle expresses JNK and that muscle contraction markedly increases JNK activation (26) . Although the degree to which IL-6 is activated in skeletal muscle by these signaling pathways is not known, it is possible that during more intense muscular activity serial activation of these various pathways gives rise to the more pronounced IL-6 response.
The biological roles of IL-6 appear to be several. The IL-6 production is modulated by the glycogen content in muscles (4, 17) and thus appears to work as an energy sensor (27) . IL-6 exerts its effect on adipose tissue, inducing lipolysis and increases whole body lipid oxidation (5) . The findings from the present study have further supported our hypothesis of IL-6 as a muscle-fiber derived hormone that is released from the site of energy turnover.
We found that IL-6 was produced equally by Type 1 and Type 2 muscle fibers. Given that IL-6 works as an energy-sensor, it could be expected that the slow, more metabolic active Type 1 muscle fibers would express more IL-6 than Type 2 fibers. It could be argued that IL-6 is produced by Type 1 fibers but taken up by Type 2 fibers. However, the immunohistochemical appearance does not support such a notion, as there was no gradient between the fiber types. Moreover, it has been argued that Ca plays a key role in inducing the signaling of IL-6. This leads to the question of whether the signaling pathway is the same in the two fiber types as the free Ca-concentration in the cytosol varies when the Type 1 versus the Type 2 fibers are activated. The phasic response of the Type 2 fibers when activated may, however, be modified when they are recruited in more prolonged dynamic exercise and have a pattern that mimics the activation of the Type 1 fibers (28, 29) . However, it makes sense that both fiber types express IL-6, as it is well-documented that human Type 2 fibers are recruited in prolonged dynamic exercise and are able to oxidize fat for its energy needs (30) . However, single-fiber studies are required to finally decide whether IL-6 is differentially expressed by fiber types.
IL-6 is not only related to energy mobilization in response to exercise. Recent findings from our group have demonstrated an anti-inflammatory effect of exercise in humans in response to endotoxin-induced TNF-α plasma levels, an effect that can fully be mimicked by IL-6 administration alone (31) . The fact that IL-6 can inhibit endotoxin-induced TNF-α demonstrates another potential benefit of muscle-derived IL-6. TNF-α has been linked to insulin resistance by inhibiting glucose uptake in skeletal muscle (32) . As muscle-derived IL-6 can inhibit a TNF-α response, IL-6 may directly bring glucose uptake back to normal levels, thus reversing the detrimental effects of TNF-α. For this effect to occur, it would seem reasonable that the muscle cells themselves would secrete IL-6 in an attempt to reverse the effects of TNF-α on muscle cell glucose uptake. These speculations are in accordance with the findings from the present study. In conclusion, the present study demonstrates that skeletal muscle cells are the dominant cell source of exercise-induced muscle-derived IL-6. Resting subjects at 1/2 h (A) and 6 h (B) show no significant IL-6 immunostaining. C) Before exercise began, IL-6 expression was generally absent in the muscle tissue. D) By 3 h, when the exercise had just ended, the muscle tissue showed significantly increased IL-6 immunoreactivity. E-G) By 4.5 (E), 6 (F), and 9 h (G), the IL-6 expression was still significantly increased relative to that of resting muscle tissue. H) By 24 h, the IL-6 levels had decreased but was still clearly higher than those of resting muscle tissue. Scale bars: A-H) 50 µm. 
